#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16448	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2078	786.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1719	1719	T	886	T,C	803,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16448	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2078	786.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1453	1453	C	967	C	892	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30022	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3622	826.7	0	.	n	.	0	T695C	SNP	695	695	T	1092	1092	C	922	C,T	845,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30022	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3622	826.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2368	2368	C	1009	C,A	915,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30022	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3622	826.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2442	2442	A	933	A	875	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30022	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3622	826.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2994	2994	C	933	C	871	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2286	folP	855	855	100.0	folP.l6.c30.ctg.1	1555	146.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1014	1016	AGC	230;230;228	A;G;C	213;213;211	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5804	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3415	169.4	1	SNP	p	S91F	0	.	.	271	273	TCC	593	595	TCC	214;215;216	T;C;C	200;199;202	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5804	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3415	169.4	1	SNP	p	D95G	0	.	.	283	285	GAC	605	607	GAC	211;209;209	G;A;C	193;188;193	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5804	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3415	169.4	1	SNP	p	D95N	0	.	.	283	285	GAC	605	607	GAC	211;209;209	G;A;C	193;188;193	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1888	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1269	147.7	1	SNP	p	G45D	0	.	.	133	135	GGC	438	440	GGC	221;223;223	G;G;C	206;209;205	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	976	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	959	100.4	0	.	n	.	0	A197.	DEL	197	197	A	520	520	A	233	A	218	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5442	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2907	186.5	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1465	1467	ATC	232;231;231	A;T;C	212;210;207	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5442	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2907	186.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1618	1620	GCA	218;218;221	G;C;A	194;195;197	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5442	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2907	186.5	1	SNP	p	D86N	0	.	.	256	258	GAC	571	573	GAC	230;230;232	G;A;C	215;211;218	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5442	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2907	186.5	1	SNP	p	S87I	0	.	.	259	261	AGT	574	576	AGT	230;229;228	A,C;G;T,C	215,1;215;211,1	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5442	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2907	186.5	1	SNP	p	S87R	0	.	.	259	261	AGT	574	576	AGT	230;229;228	A,C;G;T,C	215,1;215;211,1	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5442	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2907	186.5	1	SNP	p	S87W	0	.	.	259	261	AGT	574	576	AGT	230;229;228	A,C;G;T,C	215,1;215;211,1	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5442	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2907	186.5	1	SNP	p	S88P	0	.	.	262	264	TCC	577	579	TCC	228;230;231	T;C;C	211;216;217	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4840	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2730	176.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1540	1542	GGC	259;256;255	G;G;C	240;241;236	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	4476	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	179.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1333	1335	GCA	249;249;251	G;C;A	229;227;230	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4476	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	179.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1336	1338	ATC	250;252;258	A;T;C	230;232;239	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4476	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	179.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1348	1350	GTG	254;259;260	G;T;G	236;240;240	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4476	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	179.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1348	1350	GTG	254;259;260	G;T;G	236;240;240	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4476	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	179.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1852	1854	ACC	218;216;218	A,C;C;C	194,1;198;199	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4476	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	179.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1906	1908	GCG	194;190;188	G;C,G;G	173;158,1;165	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4476	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	179.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1906	1908	GCG	194;190;188	G;C,G;G	173;158,1;165	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4476	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	179.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2029	2031	GGC	181;179;177	G,A;G;C	165,1;162;157	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4476	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	179.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2038	2040	GGC	173;171;171	G;G;C	157;155;153	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4476	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	179.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2056	2058	CCG	147;154;156	C,G;C;G,C	100,7;107;108,1	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6442	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	3076	208.9	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1476	1478	ACG	215;216;214	A;C;G	192;192;194	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2314	porA	1146	1146	99.39	porA.l6.c30.ctg.1	1751	131.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	399	401	GGC	150;147;144	G,A;G;C	142,1;140;137	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2314	porA	1146	1146	99.39	porA.l6.c30.ctg.1	1751	131.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	581	581	C	173	C	159	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	0	.	p	.	0	T26A	NONSYN	76	78	ACC	341	343	GCC	293;289;289	G,T;C;C	271,1;269;270	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	0	.	p	.	0	K41D	NONSYN	121	123	AAA	386	388	GAC	265;265;264	G;A;C	257;251;252	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	692	694	CAA	269;271;275	C,A;A;A	245,1;248;250	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	824	826	CAA	298;297;298	C;A;A	275;276;274	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	0	.	p	.	0	N189S	NONSYN	565	567	AAC	830	832	AGC	305;302;299	A;G;C,A	283;280;277,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	0	.	p	.	0	I209M	NONSYN	625	627	ATC	890	892	ATG	280;278;277	A;T;G,C	264;262;256,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	0	.	p	.	0	.	MULTIPLE	632	633	GC	898	901	AGAT	286;290;290;296	A,G;G;A;T	269,1;274;270;276	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	0	.	p	.	0	Q213L	NONSYN	637	639	CAG	905	907	TTA	295;293;289	T;T;A	279;278;274	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	0	.	p	.	0	S216I	NONSYN	646	648	AGC	914	916	ATC	297;296;295	A;T;C	281;275;275	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	0	.	p	.	0	R256S	NONSYN	766	768	CGT	1034	1036	AGT	308;302;300	A;G;T	275;270;265	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1145	1147	AGT	269;268;266	A;G;T	250;248;243	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1151	1153	GAC	263;261;259	G;A;C	245;244;241	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	1	SNP	p	G120K	1	.	.	358	360	AAG	623	625	AAG	263;265;268	A;A;G	251;252;255	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	1	SNP	p	A121D	1	.	.	361	363	GAC	626	628	GAC	270;269;267	G;A;C	256;253;255	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3368	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	1533	217.4	1	SNP	p	D121N	0	.	.	361	363	GAC	626	628	GAC	270;269;267	G;A;C	256;253;255	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12216	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4982	244.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2070	2072	AAT	276;278;277	A;A;T	257;259;258	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1336	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	974	136.0	1	SNP	p	V57M	1	.	.	169	171	ATG	490	492	ATG	299;297;296	A;T;G	273;271;271	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
